TheraRadar
← Back
Data updated: Mar 29, 2026

PHARMOBEDIENT

CardiovascularInfectious DiseaseNeurology
Generics

PHARMOBEDIENT is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Neurology. Key products include LAMIVUDINE AND ZIDOVUDINE.

1939
Since
254
Drugs
-
Trials
2081
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 31%
20 drugs
Infectious Disease 23%
15 drugs
Neurology 15%
10 drugs
Dermatology 15%
10 drugs
Oncology 15%
10 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...